Health and Healthcare
5865 Articles
A new study from IMS Health has projected that the global market for cancer treatments rose to $107 billion in…
Nant Health entered the market with a bang on Thursday. Despite pricing at $14 per share, the stock opened at…
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology…
Clearside Biomedical expects to price more than 7 million shares at $7 per share for an initial public offering valued…
StemCells just reminded investors and speculators alike just how dangerous it can be to invest in biotech and biohealth companies.
AC Immune has filed with the U.S. Securities & Exchange Commission (SEC) to pursue an initial public offering (IPO).
Jazz Pharmaceuticals announced Tuesday morning that it has reached a definitive agreement to acquire Celator Pharmaceuticals for about $1.5 billion.
Medical device maker Medtronic reported fourth-quarter and fiscal-year 2016 results before U.S. markets opened Tuesday morning.
Mississippi has the most obese residents of any of the 50 states. As a by-product, cases of diabetes and the…
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers…
Here are seven speculative biotech and biohealth players in which analyst calls during the week ending May 27 have given…
Shares of Titan Pharmaceuticals saw a handy gain early in Friday’s session following the U.S. Food and Drug Administration (FDA)…
Thermo Fisher Scientific said Friday morning that it has agreed to acquire FEI for approximately $4.2 billion in cash.
These two biotech companies not only have data that could prove to be huge, but the stocks have been absolutely…
Minerva Neurosciences saw its shares make absolutely massive gains on Thursday following the release of positive results from a couple…
Our top personal finance-related articles today. Your wallet will thank you later.